The rise of Viagra initially drove a surge for pharma, but recent shifts present a murky scenario for shareholders. Generic alternatives are eroding revenue, and ongoing patent challenges add additional complexity to https://lulumyie844512.wssblogs.com/41082764/viagra-and-big-pharma-a-precarious-bet